pimozide has been researched along with Electrocardiogram QT Prolonged in 9 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (11.11) | 18.2507 |
2000's | 5 (55.56) | 29.6817 |
2010's | 3 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, XL; Kang, J; Kongsamut, S; Rampe, D; Roehr, J | 1 |
Cavalli, A; De Ponti, F; Poluzzi, E; Recanatini, M | 1 |
Pearlstein, R; Rampe, D; Vaz, R | 1 |
Calì, PV; Di Pino, A; Gulisano, M; Rizzo, R | 1 |
Bhattaram, A; Gobburu, J; Laughren, TP; Mathis, M; Pacanowski, M; Rogers, HL; Zineh, I | 1 |
Preskorn, SH | 1 |
Abe, J; Hamada, Y; Harada, T; Hashimoto, K; Horii, I; Sawada, Y; Shiotani, M | 1 |
Cardinal, R; Daleau, P; Drolet, B; Rousseau, G; Simard, C; Turgeon, J | 1 |
Bernstein, M | 1 |
1 review(s) available for pimozide and Electrocardiogram QT Prolonged
Article | Year |
---|---|
Understanding the structure-activity relationship of the human ether-a-go-go-related gene cardiac K+ channel. A model for bad behavior.
Topics: Cation Transport Proteins; DNA-Binding Proteins; Drug-Related Side Effects and Adverse Reactions; ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Humans; Long QT Syndrome; Models, Molecular; Pharmaceutical Preparations; Potassium Channels; Potassium Channels, Voltage-Gated; Structure-Activity Relationship; Torsades de Pointes; Trans-Activators; Transcriptional Regulator ERG | 2003 |
8 other study(ies) available for pimozide and Electrocardiogram QT Prolonged
Article | Year |
---|---|
A comparison of the receptor binding and HERG channel affinities for a series of antipsychotic drugs.
Topics: Animals; Antipsychotic Agents; Cation Transport Proteins; Cell Line; Clinical Trials as Topic; Cricetinae; DNA-Binding Proteins; ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Humans; Long QT Syndrome; Patch-Clamp Techniques; Potassium Channel Blockers; Potassium Channels; Potassium Channels, Voltage-Gated; Radioligand Assay; Receptor, Serotonin, 5-HT2A; Receptors, Dopamine D2; Receptors, Serotonin; Trans-Activators; Transcriptional Regulator ERG | 2002 |
Toward a pharmacophore for drugs inducing the long QT syndrome: insights from a CoMFA study of HERG K(+) channel blockers.
Topics: Anti-Arrhythmia Agents; Cation Transport Proteins; Cluster Analysis; Databases, Factual; Ether-A-Go-Go Potassium Channels; Long QT Syndrome; Models, Molecular; Molecular Conformation; Potassium Channel Blockers; Potassium Channels; Potassium Channels, Voltage-Gated; Quantitative Structure-Activity Relationship | 2002 |
Mandatory electrocardiographic monitoring in young patients treated with psychoactive drugs.
Topics: Antipsychotic Agents; Child; Electrocardiography; Fluoxetine; Humans; Long QT Syndrome; Male; Pimozide; Selective Serotonin Reuptake Inhibitors; Tourette Syndrome | 2013 |
CYP2D6 genotype information to guide pimozide treatment in adult and pediatric patients: basis for the U.S. Food and Drug Administration's new dosing recommendations.
Topics: Adult; Child; Cytochrome P-450 CYP2D6; Dopamine Antagonists; Dose-Response Relationship, Drug; Drug Labeling; Drug Monitoring; Genetic Testing; Humans; Long QT Syndrome; Maximum Tolerated Dose; Metabolic Clearance Rate; Pimozide; Polymorphism, Genetic; Practice Guidelines as Topic; Precision Medicine; Tourette Syndrome; United States | 2012 |
Changes in the product label for pimozide illustrate both the promises and the challenges of personalized medicine.
Topics: Cytochrome P-450 CYP2D6; Dopamine Antagonists; Humans; Long QT Syndrome; Pimozide; Polymorphism, Genetic; Precision Medicine; Tourette Syndrome | 2012 |
Practical application of guinea pig telemetry system for QT evaluation.
Topics: Animals; Anti-Arrhythmia Agents; Antipsychotic Agents; Bepridil; Cisapride; Disease Models, Animal; Electrocardiography; Guinea Pigs; Haloperidol; Heart; Humans; Injections, Intravenous; Long QT Syndrome; Male; Nifedipine; Pimozide; Piperidines; Pyridines; Quinidine; Reproducibility of Results; Telemetry; Terfenadine; Thioridazine | 2005 |
Pimozide (Orap) prolongs cardiac repolarization by blocking the rapid component of the delayed rectifier potassium current in native cardiac myocytes.
Topics: Action Potentials; Animals; Antipsychotic Agents; Buffers; Guinea Pigs; Heart; In Vitro Techniques; Long QT Syndrome; Myocardium; Patch-Clamp Techniques; Perfusion; Pimozide; Potassium Channels; Tachycardia, Ventricular | 2001 |
Pimozide and tricyclics.
Topics: Antidepressive Agents, Tricyclic; Arrhythmias, Cardiac; Drug Therapy, Combination; Electrocardiography; Humans; Long QT Syndrome; Pimozide | 1990 |